Japan Suspends Pfizer, Sanofi-Aventis Vaccines After Four Deaths
This article was originally published in PharmAsia News
Executive Summary
Japan ordered a temporary halt to use of two vaccines, one made by U.S.-based Pfizer, the other by France's Sanofi-Aventis, following four pediatric deaths
|
Japan ordered a temporary halt to use of two vaccines, one made by U.S.-based Pfizer, the other by France's Sanofi-Aventis, following four pediatric deaths. The health ministry suspended use of Pfizer's Prevenar, a pneumococcal conjugate vaccine, and the Sanofi-Aventis vaccine ActHIB, for preventing the Type B haemophilus influenza. The ministry said the suspensions would stay in force while it investigates the four deaths. (Click here for more - a subscription may be required) "Health Ministry Suspends Use Of Pfizer's Prevenar, Sanofi's ActHIB' - Nikkei (Japan) (3/7/11) |